Evidence map›Paper›PMID 18064650›Full record

ArticleJournal of cellular physiology2008

Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection.

Anna A Birukova, Tatiana Zagranichnaya, Elena Alekseeva, Gary M Bokoch, Konstantin G Birukov

Open access · greenAbstract read
In one paragraph

Article in Journal of cellular physiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 139 citations in OpenAlex.

  1. Review
  2. Article
  3. Prostaglandin EFrontiers in pharmacology · 2025
    Article
  4. Molecular Mechanisms Regulating Vascular Endothelial Permeability.International journal of molecular sciences · 2024
    Review
  5. Deletion of thePulmonary circulation · 2023
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Protein kinase A inhibitor proteins (PKIs) divert GPCR-Gαs-cAMP signaling toward EPAC and ERK activation and are involved in tumor growth.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Anna A BirukovaSection of Pulmonary and Critical Care Medicine, Department of Medicine, University of Chicago, Chicago, Illinois 60637, USA. abirukov@medicine.bsd.uchicago.edu
Tatiana Zagranichnaya
Elena Alekseeva
Gary M Bokoch
Konstantin G Birukov
University of Chicago · USScripps Research Institute · USUniversity of Illinois Chicago · US

Funding

Control of Lung Permeability by Oxidized PhospholipidsR01HL076259 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BIRUKOV, KONSTANTIN · 2004 to 2023
$6.8M
Mechanochemical regulation of endothelial permeabilityR01HL075349 · NHLBI · UNIVERSITY OF CHICAGO · PI BIRUKOV, KONSTANTIN · 2004 to 2007
$1.4M
NHLBI NIH HHS R01 HL075349NHLBI NIH HHS R01 HL076259
6 · The paper itself

Abstract

Acute lung injury, sepsis, lung inflammation, and ventilator-induced lung injury are life-threatening conditions associated with lung vascular barrier dysfunction, which may lead to pulmonary edema. Increased levels of atrial natriuretic peptide (ANP) in lung circulation reported in these pathologies suggest its potential role in the modulation of lung injury. Besides well recognized physiological effects on vascular tone, plasma volume, and renal function, ANP may exhibit protective effects in models of lung vascular endothelial cell (EC) barrier dysfunction. However, the molecular mechanisms of ANP protective effects are not well understood. The recently described cAMP-dependent guanine nucleotide exchange factor (GEF) Epac activates small GTPase Rap1, which results in activation of small GTPase Rac-specific GEFs Tiam1 and Vav2 and Rac-mediated EC barrier protective responses. Our results show that ANP stimulated protein kinase A and the Epac/Rap1/Tiam/Vav/Rac cascade dramatically attenuated thrombin-induced pulmonary EC permeability and the disruption of EC monolayer integrity. Using pharmacological and molecular activation and inhibition of cAMP-and cGMP-dependent protein kinases (PKA and PKG), Epac, Rap1, Tiam1, Vav2, and Rac we linked ANP-mediated protective effects to the activation of Epac/Rap and PKA signaling cascades, which dramatically inhibited the Rho pathway of thrombin-induced EC hyper-permeability. These results suggest a novel mechanism of ANP protective effects against agonist-induced pulmonary EC barrier dysfunction via inhibition of Rho signaling by Epac/Rap1-Rac and PKA signaling cascades.

Indexed as

ActinsAtrial Natriuretic FactorBlood-Air BarrierCells, CulturedCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic GMPEndothelial CellsEnzyme ActivationEnzyme InhibitorsGuanine Nucleotide Exchange FactorsHumansLungMonomeric GTP-Binding ProteinsProto-Oncogene Proteins c-vavrac GTP-Binding ProteinsActinsAtrial Natriuretic FactorCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic GMPEnzyme InhibitorsGuanine Nucleotide Exchange FactorsMonomeric GTP-Binding ProteinsProto-Oncogene Proteins c-vavrac GTP-Binding ProteinsRAPGEF3 protein, humanrho GTP-Binding ProteinsThrombinTIAM1 protein, humanT-Lymphoma Invasion and Metastasis-inducing Protein 1VAV2 protein, human

Identifiers

PMID18064650
PMCPMC3652875
OpenAlexW2121134435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.